CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 10415007)

Published in J Immunol on August 01, 1999

Authors

H Sepulveda1, A Cerwenka, T Morgan, R W Dutton

Author Affiliations

1: Molecular Pathology Program, University of California at San Diego, La Jolla 92093.

Articles by these authors

Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93

A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA (1997) 6.55

Immunization of normal mouse spleen cell suspensions in vitro. Science (1966) 6.47

Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique. J Exp Med (1967) 5.78

A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02

Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity. J Exp Med (1972) 3.80

Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol (2001) 3.68

An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten. J Immunol (1970) 3.63

Hypertension treated by salt restriction. Lancet (1978) 3.59

Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33

Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. Proc Natl Acad Sci U S A (1981) 3.28

Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21

Cellular events in the immune response : analysis and in vitro response of mouse spleen cell populations separated by differential flotation in albumin gradients. J Exp Med (1968) 3.12

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med (1994) 3.02

Radioresistance of the enhancing effect of cells from carrier-immunized mice in an in vitro primary immune response. Proc Natl Acad Sci U S A (1971) 2.79

DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity (2000) 2.75

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59

Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56

Evaluating laboratory performance on quality indicators with the six sigma scale. Arch Pathol Lab Med (2000) 2.55

Immune response restoration with macrophage culture supernatants. Science (1971) 2.37

Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells. J Exp Med (1973) 2.33

Separate signals for the initiation of proliferation and differentiation in the b cell response to antigen. Transplant Rev (1975) 2.32

Suppressor T cells. Transplant Rev (1975) 2.28

NKG2D ligands in tumor immunity. Oncogene (2008) 2.26

Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J Exp Med (1982) 2.22

Permeability of the loop of Henle, vasa recta, and collecting duct to water, urea, and sodium. Am J Physiol (1968) 2.10

Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med (1999) 2.09

Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol (1999) 1.99

Cell components in the immune response. II. Cell attachment separation of immune cells. Cell Immunol (1970) 1.94

Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause (1999) 1.88

Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84

The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased. Br J Clin Pharmacol (1976) 1.80

Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73

Immunoglobulins on the surface of thymus-derived cells engaged in the initiation of a humoral immune response. J Exp Med (1971) 1.73

The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells. Eur J Immunol (1981) 1.72

Cell components in the immune response. 3. Neonatal thymectomy: restoration in culture. Cell Immunol (1970) 1.66

A study by continuous microperfusion of water and electrolyte movements in the loop of Henle and distal tubule of the rat. Nephron (1969) 1.64

Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats. J Exp Med (1965) 1.63

Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol (2001) 1.63

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol (1996) 1.60

Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology (2005) 1.57

The effect of presentation and mode of delivery on neonatal outcome in the second twin. Am J Obstet Gynecol (1992) 1.57

Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med (1983) 1.56

Continuously proliferating allospecific T cells. I. Specificity of cooperation with allogeneic B cells in the humoral antibody response to sheep erythrocytes. J Exp Med (1979) 1.54

Quality assurance methods and phantoms for magnetic resonance imaging: report of AAPM nuclear magnetic resonance Task Group No. 1. Med Phys (1990) 1.48

Carotid stenosis in lacunar stroke. Stroke (1991) 1.46

Antigen receptor molecules: inhibition by antiserum against kappa light chains. Science (1970) 1.46

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med (1994) 1.45

Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit Dial Int (1993) 1.44

The significance of T-B collaboration across haplotype barriers. Cold Spring Harb Symp Quant Biol (1977) 1.44

The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion. Immunol Rev (1988) 1.44

T cell replacing factors in the B cell response to antigen. Immunol Rev (1982) 1.44

In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol (1998) 1.43

Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity (2001) 1.43

A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med (1999) 1.39

Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice. J Exp Med (1966) 1.39

Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. J Exp Med (1977) 1.39

Treating disability in knee osteoarthritis with exercise therapy: a central role for self-efficacy and pain. Arthritis Care Res (1998) 1.38

Cell components in the immune response. IV. Relationships and possible interactions. Cell Immunol (1970) 1.36

Symposium on in vitro studies of the immune response. II. Significance of the reaction of lymphoid cells to homologous tissue. Bacteriol Rev (1966) 1.36

Separation of helper and suppressor T lymphocytes on a ficoll velocity sedimentation gradient. J Exp Med (1976) 1.36

The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J Immunol (2001) 1.34

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol (1999) 1.34

Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response. J Immunol (1977) 1.30

Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta (1998) 1.29

In vitro permeability of medullary collecting ducts to water and urea. Am J Physiol (1968) 1.26

The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens. J Immunol (1975) 1.25

Production of Con A-induced helper T cell replacing factor requires a T cell and an Ia-positive non-T cells. J Immunol (1980) 1.23

Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J Exp Med (1971) 1.23

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. Gastroenterology (2000) 1.21

Restoration of renal function by arterial surgery. Lancet (1974) 1.21

Compliance to exercise therapy in older participants with knee osteoarthritis: implications for treating disability. Med Sci Sports Exerc (1997) 1.21

A microperfusion study of influence of macula densa on glomerular filtration rate. Am J Physiol (1971) 1.20

In vitro studies of immunological responses of lymphoid cells. Adv Immunol (1967) 1.20

Stimulation of DNA synthesis in cultures of mouse spleen cell suspensions by bovine transferrin. Exp Cell Res (1969) 1.18

B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Exp Med (1987) 1.17

Mutations in FLNB cause boomerang dysplasia. J Med Genet (2005) 1.16

Analysis of histocompatibility requirements for proliferative and helper T cell activity. T cell populations depleted of alloreactive cells by negative selection. J Exp Med (1980) 1.14

Role of social class in excess black stroke mortality. Stroke (1995) 1.13

Partial purification and characterization of a BCGFII from EL4 culture supernatants. J Immunol (1984) 1.13

Alloantigen-induced T helper activity. I. Minimal genetic differences necessary to induce a positive allogeneic effect. J Immunol (1978) 1.10

A study of caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): a potential model for aging research. J Gerontol A Biol Sci Med Sci (1997) 1.09

Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology (2003) 1.09

Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology (1986) 1.08

Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet (2004) 1.08

Ly phenotypes and MHC recognition: the allohelper that recognizes K or D is a mature Ly123 cell. J Immunol (1979) 1.06

Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl (1986) 1.05

Fine specificity mapping of two allospecific T cell lines: recognition of private specificities in the H-2 IA subregion. Eur J Immunol (1981) 1.04

Optimal dose of a thiazide diuretic. Med J Aust (1976) 1.04

Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. J Immunol (1999) 1.03

Competition between concanavalin A-induced stimulatory and inhibitory effects in the in vitro immune response to antigen. J Exp Med (1975) 1.02

Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. J Immunol (2001) 1.01

In vivo perfusion of proximal tubules of the rat: glomerulotubular balance. Am J Physiol (1969) 1.00

Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am J Pathol (2001) 0.99

Evidence for two distinct activation states available to B lymphocytes. J Immunol (1984) 0.98

Evidence that Con A induces cytotoxicity in the same subclass of T cells as does alloimmunization. J Immunol (1977) 0.98

Perfused Kupffer cell mass. Correlation with histology and severity of chronic liver disease. Dig Dis Sci (1995) 0.98

Improving geometric model construction for blood flow modeling. IEEE Eng Med Biol Mag (1999) 0.97

The effect of ketanserin in essential hypertension. Clin Exp Pharmacol Physiol (1983) 0.97